Serum Institute plans to start vaccine production outside India: Report

Adar Poonawalla said last week that the Serum Institute would be able to raise its monthly output to 100 million doses by July

The Serum Institute of India, which manufactures the AstraZeneca coronavirus (Covid-19) vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief executive officer told The Times.

"There's going to be an announcement in the next few days," Adar Poonawalla was quoted as saying by the newspaper in an interview published on Friday.

Poonawalla said last week that the Serum Institute would be able to raise its monthly output to 100 million doses by July, later than a previous timeline of end-May. Several states in India have run out of vaccines against Covid-19.

He hoped